Cold Induced Activation of Brown Adipose Tissue in Humans (COLDBAT)

March 23, 2018 updated by: Susanna Søberg

Cold Induced Activation of Brown Fat in Humans Assessed With PET/MR Scans and Skin-temperature Measure - A Cross-over Randomized Controlled Trial.

This study investigates cold-induced brown fat activation assessed using PET/MR scans. Subjects will participate in an acute cooling intervention day and a thermoneutral intervention day with PET/MR scans on both days. A secondary purpose is to make a validation of an infrared thermography camera by comparison of skin temperatures and SUV of the supraclavicular brown adipose tissue.

Study Overview

Detailed Description

The field of human brown adipose tissue (BAT) research is focused on activation of BAT as a means of manipulating energy expenditure and potentially anti-obesity and anti-diabetic properties of the tissue. This is well established in rodent studies and explained as due to the specific brown fat uncoupling protein 1 (UCP1). Despite increasing evidence that indicates a metabolic regulatory role of BAT in humans, BAT activation/recruitment is not fully understood and even less is known about the endocrine capacities of human BAT.

Cold induced brown fat activity will be assessed with PET/MR scans and validate an infra-red thermography camera, as well as perform a proteomic screening using blood samples under these two intervention days.

15 healthy lean male subjects will serve as their own control in a cross-over randomized control study, including a pre-examination day, a thermoneutral-day and a cooling test-day with cold exposure followed by a PET/MR scan to determine BAT activity. An extra cooling day is applied for the external validation of the infrared thermography camera. Blood samples and abdominal fat-biopsies will be taken at thermoneutral condition and under cold stimulation of brown fat.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Center for Inflammation and Metabolism/ Center for Physical Activity Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Age 18-30 years.
  • Men
  • Caucasian white
  • Body Mass Index 19-25 kg/m2.
  • Moderate physical activity level (not more than 8-10 hours of training pr. Week)
  • Ability to give informed consent.
  • Ability to follow verbal and written instructions in Danish.
  • Body fat percent under 21% measured at the pre-examination day.

Exclusion Criteria:

  • Chronic diseases: Hormonal: Metabolic Diseases mb. Graves, hypothyroidism, myxedema and goiter. Diabetes Melitus, Coronary heart disease (history of myocardial infarction, unstable angina pectoris, or congestive heart failure), cancer treated within last 3 years.
  • Tobacco, marijuana or intravenous drug use within 1 year of screening.
  • Dieting, recent weight loss (>3 kg within 3 month) or a history of an eating disorder.
  • Dietary supplements.
  • History of depression, psychosis, or other psychiatric illness requiring hospitalization.
  • Alcohol consumption >14 units/week.
  • History of alcohol abuse within the past 3 years.
  • Known liver disease or elevated liver biomarkers more than 2 times upper normal levels in the preliminary investigation.
  • Known kidney disease or elevated kidney biomarkers, eCRF <60 ml/min, in the preliminary investigation.
  • Use of daily medications, except for seasonal use of antihistamines.
  • Diagnosed sleep disturbances.
  • Pacemaker or other electronics implanted in the body.
  • Magnetic impressionable metal implants or foreign objects in the body inconsistent with completion of MR.
  • Claustrophobia
  • Communication problems, including understanding the experimental protocol
  • History of contrast allergy.
  • Winter swimmers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cooling
Individualized cooling protocol.
Individualized cooling protocol.
Other Names:
  • Cold activation
  • Cold stimulation
  • Cold activation of BAT
Experimental: Thermoneutral
Thermoneutral condition day.
Thermoneutral control day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in brown adipose tissue (BAT) activity after cooling versus no cooling.
Time Frame: Difference in SUV mean after 2 hours of cooling versus 2 hours of no cooling.
BAT activity is measured by standard fluorodeoxyglukose uptake volume (SUV mean) in the supraclavicular BAT depot using PET/MR scans. Difference between scans performed after 2 hours of cooling and 2 hours of no cooling is calculated.
Difference in SUV mean after 2 hours of cooling versus 2 hours of no cooling.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in BAT activity after cooling versus no cooling.
Time Frame: Difference in peak temperature after 2 hours of cooling versus 2 hours of no cooling.
BAT activity is measured by skin temperature in the supraclavicular BAT depot using infrared thermography imaging. Difference between peak temperature change (peak temperature minus baseline temperature) during 2 hours of cooling and 2 hours of no cooling is calculated.
Difference in peak temperature after 2 hours of cooling versus 2 hours of no cooling.
Difference in resting energy expenditure after cooling versus no cooling
Time Frame: Difference in resting energy expenditure after 2 hours of cooling versus 2 hours of no cooling.
Difference in resting energy expenditure after cooling versus no cooling, measured as mean difference in KJ/min.
Difference in resting energy expenditure after 2 hours of cooling versus 2 hours of no cooling.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Susanna Søberg, MSc., Center for Inflammation and Metabolism/Center for physical activity research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2017

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

March 1, 2018

Study Registration Dates

First Submitted

February 23, 2017

First Submitted That Met QC Criteria

March 23, 2017

First Posted (Actual)

March 30, 2017

Study Record Updates

Last Update Posted (Actual)

March 26, 2018

Last Update Submitted That Met QC Criteria

March 23, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • H-16038581-COLDBAT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Cooling

3
Subscribe